Effectiveness and tolerability of liraglutide for the management of weight regain following sleeve gastrectomy

Background There is currently very little research evidence on the benefits and safety of liraglutide in the management of weight regain or inadequate weight loss following metabolic and bariatric surgery. This study aimed to determine the clinical effectiveness and tolerability of liraglutide as an...

Full description

Saved in:
Bibliographic Details
Published in:Obesity science & practice 2024-02, Vol.10 (1), p.e706-n/a
Main Authors: Jamal, Mohammad, Qasem, Wafa, Hamshari, Fatima, Dsouza, Carol, Alqallaf, Nagi, Otiku, Paul, Nnaji, Chukwudi A.
Format: Article
Language:English
Subjects:
bariatric surgery
Chronic illnesses
Consent
Diabetes
Electronic health records
FDA approval
Gastrectomy
Gastrointestinal surgery
Hypertension
liraglutide
Medical records
Obesity
Original
Patients
Research ethics
sleeve‐gastrectomy
Statistical analysis
Surgical outcomes
Variables
Weight
Weight control
weight management
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background There is currently very little research evidence on the benefits and safety of liraglutide in the management of weight regain or inadequate weight loss following metabolic and bariatric surgery. This study aimed to determine the clinical effectiveness and tolerability of liraglutide as an adjunct therapy for managing weight regain and inadequate weight loss following sleeve gastrectomy (SG). Methods This was a retrospective analysis of medical records conducted at a private clinic in Kuwait. Results Data of 57 post‐SG patients were included in the analysis. The mean (±SD) pre‐treatment weight was 96.12 (29.26) kg. Following a median liraglutide treatment duration of approximately 3 months, the mean post‐treatment weight was 90.19 (26.82) kg. This represents a statistically significant mean weight loss of 5.94 (6.31) kg (p 
ISSN:2055-2238
2055-2238
DOI:10.1002/osp4.706